Atezolizumab,Cabozantinib
exelixis,roche
[' uc,(-ucsd),(-ucsf),']
 from the 's cosmic-21 - a multitargeted receptor tki, c + indicated promising clinical activity in with uc previously received platinum chemo - outcomes for 3 uc cohorts. #asco22 #oncotwitter 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.